Evidence map›Paper›PMID 34034859›Full record

ArticleeLife2021

Genome-wide CRISPRi screening identifies OCIAD1 as a prohibitin client and regulatory determinant of mitochondrial Complex III assembly in human cells.

Maxence Le Vasseur, Jonathan Friedman, Marco Jost, Jiawei Xu, Justin Yamada, Martin Kampmann, Max A Horlbeck, Michelle R Salemi, Brett S Phinney, Jonathan S Weissman and 1 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Structural evolution of the MTCH family of mitochondrial insertases.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. A genome-wide optical pooled screen reveals regulators of cellular antiviral responses.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Maxence Le VasseurDepartment of Molecular and Cellular Biology, College of Biological Sciences, University of California, Davis, Davis, United States.ORCID 0000-0001-6731-4379
Jonathan FriedmanDepartment of Molecular and Cellular Biology, College of Biological Sciences, University of California, Davis, Davis, United States.ORCID 0000-0001-8155-2429
Marco JostDepartment of Cellular and Molecular Pharmacology, University of California at San Francisco, San Francisco, United States.ORCID 0000-0002-1369-4908
Jiawei XuDepartment of Molecular and Cellular Biology, College of Biological Sciences, University of California, Davis, Davis, United States.ORCID 0000-0002-8534-2493
Justin YamadaDepartment of Molecular and Cellular Biology, College of Biological Sciences, University of California, Davis, Davis, United States.
Martin KampmannDepartment of Cellular and Molecular Pharmacology, University of California at San Francisco, San Francisco, United States.ORCID 0000-0002-3819-7019
Max A HorlbeckDepartment of Cellular and Molecular Pharmacology, University of California at San Francisco, San Francisco, United States.ORCID 0000-0002-3875-871X
Michelle R SalemiProteomics Core Facility, University of California, Davis, Davis, United States.
Brett S PhinneyProteomics Core Facility, University of California, Davis, Davis, United States.
Jonathan S WeissmanDepartment of Cellular and Molecular Pharmacology, University of California at San Francisco, San Francisco, United States.
Jodi NunnariDepartment of Molecular and Cellular Biology, College of Biological Sciences, University of California, Davis, Davis, United States.ORCID 0000-0002-2249-8730
University of California, Davis · USHoward Hughes Medical Institute · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007618 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANDERSON, MARK S · 1985 to 2020
$29.6M
Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human DiseaseRM1HG009490 · NHGRI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI Brittany S. Adamson, Martin Joseph Ankrah Aryee · 2017 to 2026
$22.7M
Integrative Program in Complex Biological System (ipCBS)T32EB009383 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARSHALL, WALLACE, WEINER, ORION D · 2009 to 2022
$3.2M
Supplement Request for High throughput Image Analysis SystemR37GM097432 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI NUNNARI, JODI M. · 2015 to 2020
$2.4M
Cellular basis of mtDNA transmission.R01GM126081 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI NUNNARI, JODI M. · 2017 to 2020
$1.2M
Regulation of mitochondrial inner membrane organizationR00HL133372 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI FRIEDMAN, JONATHAN R. · 2018 to 2020
$745k
Mechanisms linking mitochondrial form and functionR35GM141800 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI NUNNARI, JODI M. · 2021 to 2021
$656k
Phinney - Orbitrap Fusion ETDS10OD021801 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI PHINNEY, BRETT S · 2016 to 2016
$600k
UC Davis Shared Astrios Cell SorterS10OD018223 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI SHACKLETT, BARBARA L. · 2015 to 2015
$555k
Regulation of Mitochondrial Inner Membrane OrganizationK99HL133372 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FRIEDMAN, JONATHAN R. · 2016 to 2017
$308k
Deciphering the logic of glycolipid signaling at the host-microbiome interfaceK99GM130964 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOST, MARCO · 2019 to 2020
$200k
Howard Hughes Medical InstituteNHGRI NIH HHS RM1 HG009490NHLBI NIH HHS K99 HL133372NHLBI NIH HHS R00 HL133372NIBIB NIH HHS T32 EB009383NIGMS NIH HHS K99 GM130964NIGMS NIH HHS R01 GM126081NIGMS NIH HHS R35 GM141800NIGMS NIH HHS R37 GM097432NIGMS NIH HHS T32 GM007618NIH HHS S10 OD018223
6 · The paper itself

Abstract

Dysfunction of the mitochondrial electron transport chain (mETC) is a major cause of human mitochondrial diseases. To identify determinants of mETC function, we screened a genome-wide human CRISPRi library under oxidative metabolic conditions with selective inhibition of mitochondrial Complex III and identified ovarian carcinoma immunoreactive antigen (OCIA) domain-containing protein 1 (OCIAD1) as a Complex III assembly factor. We find that OCIAD1 is an inner mitochondrial membrane protein that forms a complex with supramolecular prohibitin assemblies. Our data indicate that OCIAD1 is required for maintenance of normal steady-state levels of Complex III and the proteolytic processing of the catalytic subunit cytochrome

Indexed as

CRISPR-Cas SystemsAntimycin AClustered Regularly Interspaced Short Palindromic RepeatsCRISPR-Associated Protein 9Electron Transport Complex IIIEndopeptidasesGenome-Wide Association StudyHumansK562 CellsMitochondriaNeoplasm ProteinsOxidative PhosphorylationProhibitinsProteolysisRepressor ProteinsAntimycin ACRISPR-Associated Protein 9Electron Transport Complex IIIEndopeptidasesIMMP2L protein, humanNeoplasm Proteinsovarian cancer immuno-reactive antigen domain containing 1, humanProhibitinsRepressor Proteinscell biologyComplex IIIcytochrome c1electron transport chainhumanmitochondriaprohibitinprotease

Identifiers

PMID34034859
PMCPMC8154037
OpenAlexW3164082323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.